Avantor, Inc. (NYSE: AVTR) Stock Competitors & Peer Comparison
See AVTR's competitors and their performance on the NYSE and across the wider stock market.
Peer Comparison Table: Medical - Instruments & Supplies Industry
Detailed financial metrics including price, market cap, P/E ratio, and more for AVTR and its NYSE peers.
| Symbol | Price | Change % | Market Cap | P/E Ratio | EPS | Dividend Yield |
|---|---|---|---|---|---|---|
| AVTR | $17.00 | -1.65% | 11.6B | 20.14 | $0.85 | N/A |
| ISRG | $443.06 | -1.90% | 157.5B | 46.35 | $9.62 | N/A |
| BDXA | $59.24 | -2.24% | 55.9B | 45.70 | $1.30 | +2.03% |
| BDX | $196.59 | +0.10% | 53.1B | 15.00 | $13.00 | +2.03% |
| RMD | $250.59 | -1.03% | 35.3B | 23.28 | $10.77 | +0.98% |
| MDLN | $32.34 | -4.02% | 28.4B | 23.73 | $1.36 | N/A |
| WST | $401.31 | +1.67% | 28B | 46.85 | $8.50 | +0.22% |
| HOLX | $76.01 | +0.00% | 17B | 31.54 | $2.41 | N/A |
| SOLV | $83.09 | -3.17% | 14.1B | 11.69 | $7.10 | N/A |
| BDXB | $48.16 | +1.39% | 13.7B | 7.60 | $6.33 | +2.03% |
Stock Comparison
Intuitive Surgical, Inc. (NASDAQ: ISRG)
AVTR vs ISRG Comparison October 2026
Avantor, Inc. (NYSE: AVTR) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AVTR stands at 11.6B. In comparison, ISRG has a market cap of 157.5B. Regarding current trading prices, AVTR is priced at $17.00 on the NYSE, while ISRG trades at $443.06.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AVTR currently has a P/E ratio of 20.14, whereas ISRG's P/E ratio is 46.35. In terms of profitability, AVTR's ROE is -0.10%, compared to ISRG's ROE of +0.17%. Regarding short-term risk, AVTR is more volatile compared to ISRG. This indicates higher risk in terms of short-term price fluctuations for AVTR.Check ISRG's competition here
Becton, Dickinson and Company (NYSE: BDXA)
AVTR vs BDXA Comparison October 2026
Avantor, Inc. (NYSE: AVTR) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AVTR stands at 11.6B. In comparison, BDXA has a market cap of 55.9B. Regarding current trading prices, AVTR is priced at $17.00 on the NYSE, while BDXA trades at $59.24.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AVTR currently has a P/E ratio of 20.14, whereas BDXA's P/E ratio is 45.70. In terms of profitability, AVTR's ROE is -0.10%, compared to BDXA's ROE of +0.04%. Regarding short-term risk, AVTR is less volatile compared to BDXA. This indicates lower risk in terms of short-term price fluctuations for AVTR.Check BDXA's competition here
Becton, Dickinson and Company (NYSE: BDX)
AVTR vs BDX Comparison October 2026
Avantor, Inc. (NYSE: AVTR) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AVTR stands at 11.6B. In comparison, BDX has a market cap of 53.1B. Regarding current trading prices, AVTR is priced at $17.00 on the NYSE, while BDX trades at $196.59.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AVTR currently has a P/E ratio of 20.14, whereas BDX's P/E ratio is 15.00. In terms of profitability, AVTR's ROE is -0.10%, compared to BDX's ROE of +0.04%. Regarding short-term risk, AVTR is more volatile compared to BDX. This indicates higher risk in terms of short-term price fluctuations for AVTR.Check BDX's competition here
ResMed Inc. (NYSE: RMD)
AVTR vs RMD Comparison October 2026
Avantor, Inc. (NYSE: AVTR) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AVTR stands at 11.6B. In comparison, RMD has a market cap of 35.3B. Regarding current trading prices, AVTR is priced at $17.00 on the NYSE, while RMD trades at $250.59.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AVTR currently has a P/E ratio of 20.14, whereas RMD's P/E ratio is 23.28. In terms of profitability, AVTR's ROE is -0.10%, compared to RMD's ROE of +0.24%. Regarding short-term risk, AVTR is more volatile compared to RMD. This indicates higher risk in terms of short-term price fluctuations for AVTR.Check RMD's competition here
Medline Inc. (NASDAQ: MDLN)
AVTR vs MDLN Comparison October 2026
Avantor, Inc. (NYSE: AVTR) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AVTR stands at 11.6B. In comparison, MDLN has a market cap of 28.4B. Regarding current trading prices, AVTR is priced at $17.00 on the NYSE, while MDLN trades at $32.34.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AVTR currently has a P/E ratio of 20.14, whereas MDLN's P/E ratio is 23.73. In terms of profitability, AVTR's ROE is -0.10%, compared to MDLN's ROE of +0.05%. Regarding short-term risk, AVTR is more volatile compared to MDLN. This indicates higher risk in terms of short-term price fluctuations for AVTR.Check MDLN's competition here
West Pharmaceutical Services, Inc. (NYSE: WST)
AVTR vs WST Comparison October 2026
Avantor, Inc. (NYSE: AVTR) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AVTR stands at 11.6B. In comparison, WST has a market cap of 28B. Regarding current trading prices, AVTR is priced at $17.00 on the NYSE, while WST trades at $401.31.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AVTR currently has a P/E ratio of 20.14, whereas WST's P/E ratio is 46.85. In terms of profitability, AVTR's ROE is -0.10%, compared to WST's ROE of +0.19%. Regarding short-term risk, AVTR is more volatile compared to WST. This indicates higher risk in terms of short-term price fluctuations for AVTR.Check WST's competition here
Hologic, Inc. (NASDAQ: HOLX)
AVTR vs HOLX Comparison October 2026
Avantor, Inc. (NYSE: AVTR) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AVTR stands at 11.6B. In comparison, HOLX has a market cap of 17B. Regarding current trading prices, AVTR is priced at $17.00 on the NYSE, while HOLX trades at $76.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AVTR currently has a P/E ratio of 20.14, whereas HOLX's P/E ratio is 31.54. In terms of profitability, AVTR's ROE is -0.10%, compared to HOLX's ROE of +0.11%. Regarding short-term risk, AVTR is more volatile compared to HOLX. This indicates higher risk in terms of short-term price fluctuations for AVTR.Check HOLX's competition here
Solventum Corporation (NYSE: SOLV)
AVTR vs SOLV Comparison October 2026
Avantor, Inc. (NYSE: AVTR) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AVTR stands at 11.6B. In comparison, SOLV has a market cap of 14.1B. Regarding current trading prices, AVTR is priced at $17.00 on the NYSE, while SOLV trades at $83.09.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AVTR currently has a P/E ratio of 20.14, whereas SOLV's P/E ratio is 11.69. In terms of profitability, AVTR's ROE is -0.10%, compared to SOLV's ROE of +0.29%. Regarding short-term risk, AVTR is more volatile compared to SOLV. This indicates higher risk in terms of short-term price fluctuations for AVTR.Check SOLV's competition here
Becton, Dickinson and Company (NYSE: BDXB)
AVTR vs BDXB Comparison October 2026
Avantor, Inc. (NYSE: AVTR) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AVTR stands at 11.6B. In comparison, BDXB has a market cap of 13.7B. Regarding current trading prices, AVTR is priced at $17.00 on the NYSE, while BDXB trades at $48.16.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AVTR currently has a P/E ratio of 20.14, whereas BDXB's P/E ratio is 7.60. In terms of profitability, AVTR's ROE is -0.10%, compared to BDXB's ROE of +0.04%. Regarding short-term risk, AVTR is more volatile compared to BDXB. This indicates higher risk in terms of short-term price fluctuations for AVTR.Check BDXB's competition here
Baxter International Inc. (NYSE: BAX)
AVTR vs BAX Comparison October 2026
Avantor, Inc. (NYSE: AVTR) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AVTR stands at 11.6B. In comparison, BAX has a market cap of 12.9B. Regarding current trading prices, AVTR is priced at $17.00 on the NYSE, while BAX trades at $25.48.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AVTR currently has a P/E ratio of 20.14, whereas BAX's P/E ratio is 11.98. In terms of profitability, AVTR's ROE is -0.10%, compared to BAX's ROE of -0.17%. Regarding short-term risk, AVTR is more volatile compared to BAX. This indicates higher risk in terms of short-term price fluctuations for AVTR.Check BAX's competition here
The Cooper Companies, Inc. (NASDAQ: COO)
AVTR vs COO Comparison October 2026
Avantor, Inc. (NYSE: AVTR) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AVTR stands at 11.6B. In comparison, COO has a market cap of 11.4B. Regarding current trading prices, AVTR is priced at $17.00 on the NYSE, while COO trades at $59.81.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AVTR currently has a P/E ratio of 20.14, whereas COO's P/E ratio is 13.13. In terms of profitability, AVTR's ROE is -0.10%, compared to COO's ROE of +0.07%. Regarding short-term risk, AVTR is more volatile compared to COO. This indicates higher risk in terms of short-term price fluctuations for AVTR.Check COO's competition here
Repligen Corporation (NASDAQ: RGEN)
AVTR vs RGEN Comparison October 2026
Avantor, Inc. (NYSE: AVTR) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AVTR stands at 11.6B. In comparison, RGEN has a market cap of 11.2B. Regarding current trading prices, AVTR is priced at $17.00 on the NYSE, while RGEN trades at $183.34.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AVTR currently has a P/E ratio of 20.14, whereas RGEN's P/E ratio is 97.67. In terms of profitability, AVTR's ROE is -0.10%, compared to RGEN's ROE of -0.01%. Regarding short-term risk, AVTR is less volatile compared to RGEN. This indicates lower risk in terms of short-term price fluctuations for AVTR.Check RGEN's competition here
AptarGroup, Inc. (NYSE: ATR)
AVTR vs ATR Comparison October 2026
Avantor, Inc. (NYSE: AVTR) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AVTR stands at 11.6B. In comparison, ATR has a market cap of 8B. Regarding current trading prices, AVTR is priced at $17.00 on the NYSE, while ATR trades at $126.24.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AVTR currently has a P/E ratio of 20.14, whereas ATR's P/E ratio is 22.12. In terms of profitability, AVTR's ROE is -0.10%, compared to ATR's ROE of +0.14%. Regarding short-term risk, AVTR is more volatile compared to ATR. This indicates higher risk in terms of short-term price fluctuations for AVTR.Check ATR's competition here
Bausch + Lomb Corporation (NYSE: BLCO)
AVTR vs BLCO Comparison October 2026
Avantor, Inc. (NYSE: AVTR) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AVTR stands at 11.6B. In comparison, BLCO has a market cap of 6.3B. Regarding current trading prices, AVTR is priced at $17.00 on the NYSE, while BLCO trades at $19.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AVTR currently has a P/E ratio of 20.14, whereas BLCO's P/E ratio is 27.11. In terms of profitability, AVTR's ROE is -0.10%, compared to BLCO's ROE of -0.03%. Regarding short-term risk, AVTR is more volatile compared to BLCO. This indicates higher risk in terms of short-term price fluctuations for AVTR.Check BLCO's competition here
Teleflex Incorporated (NYSE: TFX)
AVTR vs TFX Comparison October 2026
Avantor, Inc. (NYSE: AVTR) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AVTR stands at 11.6B. In comparison, TFX has a market cap of 5.9B. Regarding current trading prices, AVTR is priced at $17.00 on the NYSE, while TFX trades at $138.99.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AVTR currently has a P/E ratio of 20.14, whereas TFX's P/E ratio is 15.90. In terms of profitability, AVTR's ROE is -0.10%, compared to TFX's ROE of -0.32%. Regarding short-term risk, AVTR is more volatile compared to TFX. This indicates higher risk in terms of short-term price fluctuations for AVTR.Check TFX's competition here
Merit Medical Systems, Inc. (NASDAQ: MMSI)
AVTR vs MMSI Comparison October 2026
Avantor, Inc. (NYSE: AVTR) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AVTR stands at 11.6B. In comparison, MMSI has a market cap of 5.6B. Regarding current trading prices, AVTR is priced at $17.00 on the NYSE, while MMSI trades at $93.41.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AVTR currently has a P/E ratio of 20.14, whereas MMSI's P/E ratio is 23.92. In terms of profitability, AVTR's ROE is -0.10%, compared to MMSI's ROE of +0.09%. Regarding short-term risk, AVTR is more volatile compared to MMSI. This indicates higher risk in terms of short-term price fluctuations for AVTR.Check MMSI's competition here
Stevanato Group S.p.A. (NYSE: STVN)
AVTR vs STVN Comparison October 2026
Avantor, Inc. (NYSE: AVTR) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AVTR stands at 11.6B. In comparison, STVN has a market cap of 5.4B. Regarding current trading prices, AVTR is priced at $17.00 on the NYSE, while STVN trades at $19.71.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AVTR currently has a P/E ratio of 20.14, whereas STVN's P/E ratio is 29.76. In terms of profitability, AVTR's ROE is -0.10%, compared to STVN's ROE of +0.09%. Regarding short-term risk, AVTR is more volatile compared to STVN. This indicates higher risk in terms of short-term price fluctuations for AVTR.Check STVN's competition here
ICU Medical, Inc. (NASDAQ: ICUI)
AVTR vs ICUI Comparison October 2026
Avantor, Inc. (NYSE: AVTR) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AVTR stands at 11.6B. In comparison, ICUI has a market cap of 4.1B. Regarding current trading prices, AVTR is priced at $17.00 on the NYSE, while ICUI trades at $165.24.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AVTR currently has a P/E ratio of 20.14, whereas ICUI's P/E ratio is 20.37. In terms of profitability, AVTR's ROE is -0.10%, compared to ICUI's ROE of +0.01%. Regarding short-term risk, AVTR is more volatile compared to ICUI. This indicates higher risk in terms of short-term price fluctuations for AVTR.Check ICUI's competition here
Pulse Biosciences, Inc. (NASDAQ: PLSE)
AVTR vs PLSE Comparison October 2026
Avantor, Inc. (NYSE: AVTR) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AVTR stands at 11.6B. In comparison, PLSE has a market cap of 3.8B. Regarding current trading prices, AVTR is priced at $17.00 on the NYSE, while PLSE trades at $53.48.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AVTR currently has a P/E ratio of 20.14, whereas PLSE's P/E ratio is -45.08. In terms of profitability, AVTR's ROE is -0.10%, compared to PLSE's ROE of -0.94%. Regarding short-term risk, AVTR is more volatile compared to PLSE. This indicates higher risk in terms of short-term price fluctuations for AVTR.Check PLSE's competition here
Envista Holdings Corp (NYSE: NVST)
AVTR vs NVST Comparison October 2026
Avantor, Inc. (NYSE: AVTR) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AVTR stands at 11.6B. In comparison, NVST has a market cap of 3.8B. Regarding current trading prices, AVTR is priced at $17.00 on the NYSE, while NVST trades at $23.85.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AVTR currently has a P/E ratio of 20.14, whereas NVST's P/E ratio is 16.04. In terms of profitability, AVTR's ROE is -0.10%, compared to NVST's ROE of +0.03%. Regarding short-term risk, AVTR is more volatile compared to NVST. This indicates higher risk in terms of short-term price fluctuations for AVTR.Check NVST's competition here
AtriCure, Inc. (NASDAQ: ATRC)
AVTR vs ATRC Comparison October 2026
Avantor, Inc. (NYSE: AVTR) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AVTR stands at 11.6B. In comparison, ATRC has a market cap of 3.1B. Regarding current trading prices, AVTR is priced at $17.00 on the NYSE, while ATRC trades at $61.76.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AVTR currently has a P/E ratio of 20.14, whereas ATRC's P/E ratio is 1910.25. In terms of profitability, AVTR's ROE is -0.10%, compared to ATRC's ROE of +0.02%. Regarding short-term risk, AVTR is more volatile compared to ATRC. This indicates higher risk in terms of short-term price fluctuations for AVTR.Check ATRC's competition here
LeMaitre Vascular, Inc. (NASDAQ: LMAT)
AVTR vs LMAT Comparison October 2026
Avantor, Inc. (NYSE: AVTR) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AVTR stands at 11.6B. In comparison, LMAT has a market cap of 1.9B. Regarding current trading prices, AVTR is priced at $17.00 on the NYSE, while LMAT trades at $83.55.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AVTR currently has a P/E ratio of 20.14, whereas LMAT's P/E ratio is 30.81. In terms of profitability, AVTR's ROE is -0.10%, compared to LMAT's ROE of +0.16%. Regarding short-term risk, AVTR is more volatile compared to LMAT. This indicates higher risk in terms of short-term price fluctuations for AVTR.Check LMAT's competition here
BioLife Solutions, Inc. (NASDAQ: BLFS)
AVTR vs BLFS Comparison October 2026
Avantor, Inc. (NYSE: AVTR) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AVTR stands at 11.6B. In comparison, BLFS has a market cap of 1.9B. Regarding current trading prices, AVTR is priced at $17.00 on the NYSE, while BLFS trades at $38.61.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AVTR currently has a P/E ratio of 20.14, whereas BLFS's P/E ratio is 37.49. In terms of profitability, AVTR's ROE is -0.10%, compared to BLFS's ROE of +0.13%. Regarding short-term risk, AVTR is more volatile compared to BLFS. This indicates higher risk in terms of short-term price fluctuations for AVTR.Check BLFS's competition here
DENTSPLY SIRONA Inc. (NASDAQ: XRAY)
AVTR vs XRAY Comparison October 2026
Avantor, Inc. (NYSE: AVTR) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AVTR stands at 11.6B. In comparison, XRAY has a market cap of 1.9B. Regarding current trading prices, AVTR is priced at $17.00 on the NYSE, while XRAY trades at $9.37.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AVTR currently has a P/E ratio of 20.14, whereas XRAY's P/E ratio is 6.54. In terms of profitability, AVTR's ROE is -0.10%, compared to XRAY's ROE of -0.40%. Regarding short-term risk, AVTR is more volatile compared to XRAY. This indicates higher risk in terms of short-term price fluctuations for AVTR.Check XRAY's competition here
Kestra Medical Technologies, Ltd. (NASDAQ: KMTS)
AVTR vs KMTS Comparison October 2026
Avantor, Inc. (NYSE: AVTR) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AVTR stands at 11.6B. In comparison, KMTS has a market cap of 1.8B. Regarding current trading prices, AVTR is priced at $17.00 on the NYSE, while KMTS trades at $30.29.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AVTR currently has a P/E ratio of 20.14, whereas KMTS's P/E ratio is -11.32. In terms of profitability, AVTR's ROE is -0.10%, compared to KMTS's ROE of -0.64%. Regarding short-term risk, AVTR is more volatile compared to KMTS. This indicates higher risk in terms of short-term price fluctuations for AVTR.Check KMTS's competition here
Azenta, Inc. (NASDAQ: AZTA)
AVTR vs AZTA Comparison October 2026
Avantor, Inc. (NYSE: AVTR) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AVTR stands at 11.6B. In comparison, AZTA has a market cap of 1.7B. Regarding current trading prices, AVTR is priced at $17.00 on the NYSE, while AZTA trades at $40.73.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AVTR currently has a P/E ratio of 20.14, whereas AZTA's P/E ratio is 93.05. In terms of profitability, AVTR's ROE is -0.10%, compared to AZTA's ROE of -0.08%. Regarding short-term risk, AVTR is more volatile compared to AZTA. This indicates higher risk in terms of short-term price fluctuations for AVTR.Check AZTA's competition here
STAAR Surgical Company (NASDAQ: STAA)
AVTR vs STAA Comparison October 2026
Avantor, Inc. (NYSE: AVTR) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AVTR stands at 11.6B. In comparison, STAA has a market cap of 1.2B. Regarding current trading prices, AVTR is priced at $17.00 on the NYSE, while STAA trades at $24.33.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AVTR currently has a P/E ratio of 20.14, whereas STAA's P/E ratio is 42.39. In terms of profitability, AVTR's ROE is -0.10%, compared to STAA's ROE of +0.01%. Regarding short-term risk, AVTR is more volatile compared to STAA. This indicates higher risk in terms of short-term price fluctuations for AVTR.Check STAA's competition here
Atrion Corporation (NASDAQ: ATRI)
AVTR vs ATRI Comparison October 2026
Avantor, Inc. (NYSE: AVTR) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AVTR stands at 11.6B. In comparison, ATRI has a market cap of 809.4M. Regarding current trading prices, AVTR is priced at $17.00 on the NYSE, while ATRI trades at $459.92.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AVTR currently has a P/E ratio of 20.14, whereas ATRI's P/E ratio is 64.50. In terms of profitability, AVTR's ROE is -0.10%, compared to ATRI's ROE of +0.08%. Regarding short-term risk, AVTR is more volatile compared to ATRI. This indicates higher risk in terms of short-term price fluctuations for AVTR.Check ATRI's competition here
AngioDynamics, Inc. (NASDAQ: ANGO)
AVTR vs ANGO Comparison October 2026
Avantor, Inc. (NYSE: AVTR) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AVTR stands at 11.6B. In comparison, ANGO has a market cap of 515.6M. Regarding current trading prices, AVTR is priced at $17.00 on the NYSE, while ANGO trades at $12.24.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AVTR currently has a P/E ratio of 20.14, whereas ANGO's P/E ratio is -31.44. In terms of profitability, AVTR's ROE is -0.10%, compared to ANGO's ROE of -0.19%. Regarding short-term risk, AVTR is more volatile compared to ANGO. This indicates higher risk in terms of short-term price fluctuations for AVTR.Check ANGO's competition here
MiniMed Group, Inc. (NASDAQ: MMEDV)
AVTR vs MMEDV Comparison October 2026
Avantor, Inc. (NYSE: AVTR) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AVTR stands at 11.6B. In comparison, MMEDV has a market cap of 495.6M. Regarding current trading prices, AVTR is priced at $17.00 on the NYSE, while MMEDV trades at $17.70.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AVTR currently has a P/E ratio of 20.14, whereas MMEDV's P/E ratio is N/A. In terms of profitability, AVTR's ROE is -0.10%, compared to MMEDV's ROE of N/A. Regarding short-term risk, AVTR is more volatile compared to MMEDV. This indicates higher risk in terms of short-term price fluctuations for AVTR.Check MMEDV's competition here
Embecta Corp. (NASDAQ: EMBC)
AVTR vs EMBC Comparison October 2026
Avantor, Inc. (NYSE: AVTR) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AVTR stands at 11.6B. In comparison, EMBC has a market cap of 371.1M. Regarding current trading prices, AVTR is priced at $17.00 on the NYSE, while EMBC trades at $6.50.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AVTR currently has a P/E ratio of 20.14, whereas EMBC's P/E ratio is 2.52. In terms of profitability, AVTR's ROE is -0.10%, compared to EMBC's ROE of -0.14%. Regarding short-term risk, AVTR is more volatile compared to EMBC. This indicates higher risk in terms of short-term price fluctuations for AVTR.Check EMBC's competition here
Sanara MedTech Inc. (NASDAQ: SMTI)
AVTR vs SMTI Comparison October 2026
Avantor, Inc. (NYSE: AVTR) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AVTR stands at 11.6B. In comparison, SMTI has a market cap of 301.7M. Regarding current trading prices, AVTR is priced at $17.00 on the NYSE, while SMTI trades at $32.64.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AVTR currently has a P/E ratio of 20.14, whereas SMTI's P/E ratio is -547.33. In terms of profitability, AVTR's ROE is -0.10%, compared to SMTI's ROE of -4.74%. Regarding short-term risk, AVTR is more volatile compared to SMTI. This indicates higher risk in terms of short-term price fluctuations for AVTR.Check SMTI's competition here
OraSure Technologies, Inc. (NASDAQ: OSUR)
AVTR vs OSUR Comparison October 2026
Avantor, Inc. (NYSE: AVTR) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AVTR stands at 11.6B. In comparison, OSUR has a market cap of 286.9M. Regarding current trading prices, AVTR is priced at $17.00 on the NYSE, while OSUR trades at $4.17.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AVTR currently has a P/E ratio of 20.14, whereas OSUR's P/E ratio is -6.03. In terms of profitability, AVTR's ROE is -0.10%, compared to OSUR's ROE of -0.15%. Regarding short-term risk, AVTR is more volatile compared to OSUR. This indicates higher risk in terms of short-term price fluctuations for AVTR.Check OSUR's competition here
Utah Medical Products, Inc. (NASDAQ: UTMD)
AVTR vs UTMD Comparison October 2026
Avantor, Inc. (NYSE: AVTR) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AVTR stands at 11.6B. In comparison, UTMD has a market cap of 231.9M. Regarding current trading prices, AVTR is priced at $17.00 on the NYSE, while UTMD trades at $72.73.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AVTR currently has a P/E ratio of 20.14, whereas UTMD's P/E ratio is 21.62. In terms of profitability, AVTR's ROE is -0.10%, compared to UTMD's ROE of +0.09%. Regarding short-term risk, AVTR is more volatile compared to UTMD. This indicates higher risk in terms of short-term price fluctuations for AVTR.Check UTMD's competition here
Pro-Dex, Inc. (NASDAQ: PDEX)
AVTR vs PDEX Comparison October 2026
Avantor, Inc. (NYSE: AVTR) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AVTR stands at 11.6B. In comparison, PDEX has a market cap of 201.3M. Regarding current trading prices, AVTR is priced at $17.00 on the NYSE, while PDEX trades at $62.42.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AVTR currently has a P/E ratio of 20.14, whereas PDEX's P/E ratio is 15.08. In terms of profitability, AVTR's ROE is -0.10%, compared to PDEX's ROE of +0.31%. Regarding short-term risk, AVTR is more volatile compared to PDEX. This indicates higher risk in terms of short-term price fluctuations for AVTR.Check PDEX's competition here
Anbio Biotechnology Class A Ordinary Shares (NASDAQ: NNNN)
AVTR vs NNNN Comparison October 2026
Avantor, Inc. (NYSE: AVTR) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AVTR stands at 11.6B. In comparison, NNNN has a market cap of 169.4M. Regarding current trading prices, AVTR is priced at $17.00 on the NYSE, while NNNN trades at $3.70.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AVTR currently has a P/E ratio of 20.14, whereas NNNN's P/E ratio is 25.73. In terms of profitability, AVTR's ROE is -0.10%, compared to NNNN's ROE of +0.27%. Regarding short-term risk, AVTR is more volatile compared to NNNN. This indicates higher risk in terms of short-term price fluctuations for AVTR.Check NNNN's competition here
KORU Medical Systems, Inc. (NASDAQ: KRMD)
AVTR vs KRMD Comparison October 2026
Avantor, Inc. (NYSE: AVTR) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AVTR stands at 11.6B. In comparison, KRMD has a market cap of 145.6M. Regarding current trading prices, AVTR is priced at $17.00 on the NYSE, while KRMD trades at $3.26.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AVTR currently has a P/E ratio of 20.14, whereas KRMD's P/E ratio is -79.25. In terms of profitability, AVTR's ROE is -0.10%, compared to KRMD's ROE of -0.11%. Regarding short-term risk, AVTR is more volatile compared to KRMD. This indicates higher risk in terms of short-term price fluctuations for AVTR.Check KRMD's competition here
Stereotaxis, Inc. (AMEX: STXS)
AVTR vs STXS Comparison October 2026
Avantor, Inc. (NYSE: AVTR) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AVTR stands at 11.6B. In comparison, STXS has a market cap of 104.2M. Regarding current trading prices, AVTR is priced at $17.00 on the NYSE, while STXS trades at $1.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AVTR currently has a P/E ratio of 20.14, whereas STXS's P/E ratio is -6.12. In terms of profitability, AVTR's ROE is -0.10%, compared to STXS's ROE of -1.33%. Regarding short-term risk, AVTR is more volatile compared to STXS. This indicates higher risk in terms of short-term price fluctuations for AVTR.Check STXS's competition here
Akoya Biosciences, Inc. (NASDAQ: AKYA)
AVTR vs AKYA Comparison October 2026
Avantor, Inc. (NYSE: AVTR) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AVTR stands at 11.6B. In comparison, AKYA has a market cap of 64.4M. Regarding current trading prices, AVTR is priced at $17.00 on the NYSE, while AKYA trades at $1.29.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AVTR currently has a P/E ratio of 20.14, whereas AKYA's P/E ratio is -1.34. In terms of profitability, AVTR's ROE is -0.10%, compared to AKYA's ROE of -1.80%. Regarding short-term risk, AVTR is more volatile compared to AKYA. This indicates higher risk in terms of short-term price fluctuations for AVTR.Check AKYA's competition here
Daxor Corporation (NASDAQ: DXR)
AVTR vs DXR Comparison October 2026
Avantor, Inc. (NYSE: AVTR) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AVTR stands at 11.6B. In comparison, DXR has a market cap of 54.1M. Regarding current trading prices, AVTR is priced at $17.00 on the NYSE, while DXR trades at $8.96.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AVTR currently has a P/E ratio of 20.14, whereas DXR's P/E ratio is 7.54. In terms of profitability, AVTR's ROE is -0.10%, compared to DXR's ROE of +0.13%. Regarding short-term risk, AVTR is more volatile compared to DXR. This indicates higher risk in terms of short-term price fluctuations for AVTR.Check DXR's competition here
SkyAI, Inc. (NASDAQ: STSS)
AVTR vs STSS Comparison October 2026
Avantor, Inc. (NYSE: AVTR) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AVTR stands at 11.6B. In comparison, STSS has a market cap of 53.7M. Regarding current trading prices, AVTR is priced at $17.00 on the NYSE, while STSS trades at $1.27.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AVTR currently has a P/E ratio of 20.14, whereas STSS's P/E ratio is -0.02. In terms of profitability, AVTR's ROE is -0.10%, compared to STSS's ROE of -1.54%. Regarding short-term risk, AVTR is less volatile compared to STSS. This indicates lower risk in terms of short-term price fluctuations for AVTR.Check STSS's competition here
Singular Genomics Systems, Inc. (NASDAQ: OMIC)
AVTR vs OMIC Comparison October 2026
Avantor, Inc. (NYSE: AVTR) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AVTR stands at 11.6B. In comparison, OMIC has a market cap of 50.8M. Regarding current trading prices, AVTR is priced at $17.00 on the NYSE, while OMIC trades at $20.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AVTR currently has a P/E ratio of 20.14, whereas OMIC's P/E ratio is -0.58. In terms of profitability, AVTR's ROE is -0.10%, compared to OMIC's ROE of -0.43%. Regarding short-term risk, AVTR is more volatile compared to OMIC. This indicates higher risk in terms of short-term price fluctuations for AVTR.Check OMIC's competition here
GlucoTrack, Inc. (NASDAQ: IGAP)
AVTR vs IGAP Comparison October 2026
Avantor, Inc. (NYSE: AVTR) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AVTR stands at 11.6B. In comparison, IGAP has a market cap of 50.2M. Regarding current trading prices, AVTR is priced at $17.00 on the NYSE, while IGAP trades at $3.24.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AVTR currently has a P/E ratio of 20.14, whereas IGAP's P/E ratio is -10.52. In terms of profitability, AVTR's ROE is -0.10%, compared to IGAP's ROE of +1.80%. Regarding short-term risk, AVTR is more volatile compared to IGAP. This indicates higher risk in terms of short-term price fluctuations for AVTR.Check IGAP's competition here
Precision Optics Corporation, Inc. (NASDAQ: POCI)
AVTR vs POCI Comparison October 2026
Avantor, Inc. (NYSE: AVTR) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AVTR stands at 11.6B. In comparison, POCI has a market cap of 48.4M. Regarding current trading prices, AVTR is priced at $17.00 on the NYSE, while POCI trades at $4.44.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AVTR currently has a P/E ratio of 20.14, whereas POCI's P/E ratio is -9.59. In terms of profitability, AVTR's ROE is -0.10%, compared to POCI's ROE of -0.24%. Regarding short-term risk, AVTR is more volatile compared to POCI. This indicates higher risk in terms of short-term price fluctuations for AVTR.Check POCI's competition here
Harvard Bioscience, Inc. (NASDAQ: HBIO)
AVTR vs HBIO Comparison October 2026
Avantor, Inc. (NYSE: AVTR) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AVTR stands at 11.6B. In comparison, HBIO has a market cap of 38M. Regarding current trading prices, AVTR is priced at $17.00 on the NYSE, while HBIO trades at $8.32.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AVTR currently has a P/E ratio of 20.14, whereas HBIO's P/E ratio is -23.19. In terms of profitability, AVTR's ROE is -0.10%, compared to HBIO's ROE of -0.92%. Regarding short-term risk, AVTR is more volatile compared to HBIO. This indicates higher risk in terms of short-term price fluctuations for AVTR.Check HBIO's competition here
Nephros, Inc. (NASDAQ: NEPH)
AVTR vs NEPH Comparison October 2026
Avantor, Inc. (NYSE: AVTR) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AVTR stands at 11.6B. In comparison, NEPH has a market cap of 36.6M. Regarding current trading prices, AVTR is priced at $17.00 on the NYSE, while NEPH trades at $3.45.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AVTR currently has a P/E ratio of 20.14, whereas NEPH's P/E ratio is 56.17. In terms of profitability, AVTR's ROE is -0.10%, compared to NEPH's ROE of +0.16%. Regarding short-term risk, AVTR is more volatile compared to NEPH. This indicates higher risk in terms of short-term price fluctuations for AVTR.Check NEPH's competition here
SmileDirectClub, Inc. (NASDAQ: SDC)
AVTR vs SDC Comparison October 2026
Avantor, Inc. (NYSE: AVTR) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AVTR stands at 11.6B. In comparison, SDC has a market cap of 29.1M. Regarding current trading prices, AVTR is priced at $17.00 on the NYSE, while SDC trades at $0.08.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AVTR currently has a P/E ratio of 20.14, whereas SDC's P/E ratio is -0.03. In terms of profitability, AVTR's ROE is -0.10%, compared to SDC's ROE of -1.96%. Regarding short-term risk, AVTR is less volatile compared to SDC. This indicates lower risk in terms of short-term price fluctuations for AVTR.Check SDC's competition here
Milestone Scientific Inc. (AMEX: MLSS)
AVTR vs MLSS Comparison October 2026
Avantor, Inc. (NYSE: AVTR) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AVTR stands at 11.6B. In comparison, MLSS has a market cap of 27.7M. Regarding current trading prices, AVTR is priced at $17.00 on the NYSE, while MLSS trades at $0.31.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AVTR currently has a P/E ratio of 20.14, whereas MLSS's P/E ratio is -6.11. In terms of profitability, AVTR's ROE is -0.10%, compared to MLSS's ROE of -1.49%. Regarding short-term risk, AVTR is less volatile compared to MLSS. This indicates lower risk in terms of short-term price fluctuations for AVTR.Check MLSS's competition here
Invacare Corporation (NYSE: IVC)
AVTR vs IVC Comparison October 2026
Avantor, Inc. (NYSE: AVTR) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AVTR stands at 11.6B. In comparison, IVC has a market cap of 24.9M. Regarding current trading prices, AVTR is priced at $17.00 on the NYSE, while IVC trades at $0.66.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AVTR currently has a P/E ratio of 20.14, whereas IVC's P/E ratio is -0.79. In terms of profitability, AVTR's ROE is -0.10%, compared to IVC's ROE of -0.46%. Regarding short-term risk, AVTR is less volatile compared to IVC. This indicates lower risk in terms of short-term price fluctuations for AVTR.Check IVC's competition here
Retractable Technologies, Inc. (AMEX: RVP)
AVTR vs RVP Comparison October 2026
Avantor, Inc. (NYSE: AVTR) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AVTR stands at 11.6B. In comparison, RVP has a market cap of 17.5M. Regarding current trading prices, AVTR is priced at $17.00 on the NYSE, while RVP trades at $0.59.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AVTR currently has a P/E ratio of 20.14, whereas RVP's P/E ratio is -4.87. In terms of profitability, AVTR's ROE is -0.10%, compared to RVP's ROE of -0.05%. Regarding short-term risk, AVTR is more volatile compared to RVP. This indicates higher risk in terms of short-term price fluctuations for AVTR.Check RVP's competition here
Jin Medical International Ltd. (NASDAQ: ZJYL)
AVTR vs ZJYL Comparison October 2026
Avantor, Inc. (NYSE: AVTR) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AVTR stands at 11.6B. In comparison, ZJYL has a market cap of 15M. Regarding current trading prices, AVTR is priced at $17.00 on the NYSE, while ZJYL trades at $2.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AVTR currently has a P/E ratio of 20.14, whereas ZJYL's P/E ratio is 13.13. In terms of profitability, AVTR's ROE is -0.10%, compared to ZJYL's ROE of +0.04%. Regarding short-term risk, AVTR is more volatile compared to ZJYL. This indicates higher risk in terms of short-term price fluctuations for AVTR.Check ZJYL's competition here
Bionano Genomics, Inc. (NASDAQ: BNGO)
AVTR vs BNGO Comparison October 2026
Avantor, Inc. (NYSE: AVTR) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AVTR stands at 11.6B. In comparison, BNGO has a market cap of 14.4M. Regarding current trading prices, AVTR is priced at $17.00 on the NYSE, while BNGO trades at $1.25.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AVTR currently has a P/E ratio of 20.14, whereas BNGO's P/E ratio is -0.40. In terms of profitability, AVTR's ROE is -0.10%, compared to BNGO's ROE of -0.79%. Regarding short-term risk, AVTR is more volatile compared to BNGO. This indicates higher risk in terms of short-term price fluctuations for AVTR.Check BNGO's competition here
Femasys Inc. (NASDAQ: FEMY)
AVTR vs FEMY Comparison October 2026
Avantor, Inc. (NYSE: AVTR) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AVTR stands at 11.6B. In comparison, FEMY has a market cap of 11.5M. Regarding current trading prices, AVTR is priced at $17.00 on the NYSE, while FEMY trades at $1.39.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AVTR currently has a P/E ratio of 20.14, whereas FEMY's P/E ratio is -0.31. In terms of profitability, AVTR's ROE is -0.10%, compared to FEMY's ROE of -2.26%. Regarding short-term risk, AVTR is less volatile compared to FEMY. This indicates lower risk in terms of short-term price fluctuations for AVTR.Check FEMY's competition here
Regentis Biomaterials Ltd. (AMEX: RGNT)
AVTR vs RGNT Comparison October 2026
Avantor, Inc. (NYSE: AVTR) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AVTR stands at 11.6B. In comparison, RGNT has a market cap of 9.1M. Regarding current trading prices, AVTR is priced at $17.00 on the NYSE, while RGNT trades at $1.26.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AVTR currently has a P/E ratio of 20.14, whereas RGNT's P/E ratio is -0.53. In terms of profitability, AVTR's ROE is -0.10%, compared to RGNT's ROE of N/A. Regarding short-term risk, AVTR is more volatile compared to RGNT. This indicates higher risk in terms of short-term price fluctuations for AVTR.Check RGNT's competition here
Lucyd, Inc (NASDAQ: LUCY)
AVTR vs LUCY Comparison October 2026
Avantor, Inc. (NYSE: AVTR) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AVTR stands at 11.6B. In comparison, LUCY has a market cap of 7.1M. Regarding current trading prices, AVTR is priced at $17.00 on the NYSE, while LUCY trades at $0.85.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AVTR currently has a P/E ratio of 20.14, whereas LUCY's P/E ratio is -0.63. In terms of profitability, AVTR's ROE is -0.10%, compared to LUCY's ROE of -0.89%. Regarding short-term risk, AVTR is more volatile compared to LUCY. This indicates higher risk in terms of short-term price fluctuations for AVTR.Check LUCY's competition here
NanoString Technologies, Inc. (NASDAQ: NSTG)
AVTR vs NSTG Comparison October 2026
Avantor, Inc. (NYSE: AVTR) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AVTR stands at 11.6B. In comparison, NSTG has a market cap of 5.1M. Regarding current trading prices, AVTR is priced at $17.00 on the NYSE, while NSTG trades at $0.11.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AVTR currently has a P/E ratio of 20.14, whereas NSTG's P/E ratio is -0.03. In terms of profitability, AVTR's ROE is -0.10%, compared to NSTG's ROE of -1.43%. Regarding short-term risk, AVTR is less volatile compared to NSTG. This indicates lower risk in terms of short-term price fluctuations for AVTR.Check NSTG's competition here
Cuprina Holdings (Cayman) Limited Class A Ordinary Shares (NASDAQ: CUPR)
AVTR vs CUPR Comparison October 2026
Avantor, Inc. (NYSE: AVTR) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AVTR stands at 11.6B. In comparison, CUPR has a market cap of 4.9M. Regarding current trading prices, AVTR is priced at $17.00 on the NYSE, while CUPR trades at $1.76.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AVTR currently has a P/E ratio of 20.14, whereas CUPR's P/E ratio is -1.32. In terms of profitability, AVTR's ROE is -0.10%, compared to CUPR's ROE of -0.85%. Regarding short-term risk, AVTR is less volatile compared to CUPR. This indicates lower risk in terms of short-term price fluctuations for AVTR.Check CUPR's competition here
Predictive Oncology Inc. (NASDAQ: POAI)
AVTR vs POAI Comparison October 2026
Avantor, Inc. (NYSE: AVTR) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AVTR stands at 11.6B. In comparison, POAI has a market cap of 3.6M. Regarding current trading prices, AVTR is priced at $17.00 on the NYSE, while POAI trades at $4.91.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AVTR currently has a P/E ratio of 20.14, whereas POAI's P/E ratio is -0.38. In terms of profitability, AVTR's ROE is -0.10%, compared to POAI's ROE of -21.19%. Regarding short-term risk, AVTR is less volatile compared to POAI. This indicates lower risk in terms of short-term price fluctuations for AVTR.Check POAI's competition here
Meihua International Medical Technologies Co., Ltd. (NASDAQ: MHUA)
AVTR vs MHUA Comparison October 2026
Avantor, Inc. (NYSE: AVTR) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AVTR stands at 11.6B. In comparison, MHUA has a market cap of 2.4M. Regarding current trading prices, AVTR is priced at $17.00 on the NYSE, while MHUA trades at $7.61.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AVTR currently has a P/E ratio of 20.14, whereas MHUA's P/E ratio is 0.25. In terms of profitability, AVTR's ROE is -0.10%, compared to MHUA's ROE of +0.07%. Regarding short-term risk, AVTR is more volatile compared to MHUA. This indicates higher risk in terms of short-term price fluctuations for AVTR.Check MHUA's competition here
G Medical Innovations Holdings Ltd (NASDAQ: GMVD)
AVTR vs GMVD Comparison October 2026
Avantor, Inc. (NYSE: AVTR) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AVTR stands at 11.6B. In comparison, GMVD has a market cap of 1.8M. Regarding current trading prices, AVTR is priced at $17.00 on the NYSE, while GMVD trades at $0.18.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AVTR currently has a P/E ratio of 20.14, whereas GMVD's P/E ratio is -0.01. In terms of profitability, AVTR's ROE is -0.10%, compared to GMVD's ROE of +2.09%. Regarding short-term risk, AVTR is less volatile compared to GMVD. This indicates lower risk in terms of short-term price fluctuations for AVTR.Check GMVD's competition here
G Medical Innovations Holdings Ltd (NASDAQ: GMVDW)
AVTR vs GMVDW Comparison October 2026
Avantor, Inc. (NYSE: AVTR) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AVTR stands at 11.6B. In comparison, GMVDW has a market cap of 1.8M. Regarding current trading prices, AVTR is priced at $17.00 on the NYSE, while GMVDW trades at $7.04.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AVTR currently has a P/E ratio of 20.14, whereas GMVDW's P/E ratio is N/A. In terms of profitability, AVTR's ROE is -0.10%, compared to GMVDW's ROE of +3.68%. Regarding short-term risk, AVTR is less volatile compared to GMVDW. This indicates lower risk in terms of short-term price fluctuations for AVTR.Check GMVDW's competition here
Avinger, Inc. (NASDAQ: AVGR)
AVTR vs AVGR Comparison October 2026
Avantor, Inc. (NYSE: AVTR) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AVTR stands at 11.6B. In comparison, AVGR has a market cap of 1.5M. Regarding current trading prices, AVTR is priced at $17.00 on the NYSE, while AVGR trades at $0.47.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AVTR currently has a P/E ratio of 20.14, whereas AVGR's P/E ratio is -0.05. In terms of profitability, AVTR's ROE is -0.10%, compared to AVGR's ROE of +17.82%. Regarding short-term risk, AVTR is less volatile compared to AVGR. This indicates lower risk in terms of short-term price fluctuations for AVTR.Check AVGR's competition here
NEXGEL, Inc. (NASDAQ: NXGLW)
AVTR vs NXGLW Comparison October 2026
Avantor, Inc. (NYSE: AVTR) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AVTR stands at 11.6B. In comparison, NXGLW has a market cap of 868.5K. Regarding current trading prices, AVTR is priced at $17.00 on the NYSE, while NXGLW trades at $0.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AVTR currently has a P/E ratio of 20.14, whereas NXGLW's P/E ratio is -0.02. In terms of profitability, AVTR's ROE is -0.10%, compared to NXGLW's ROE of -1.33%. Regarding short-term risk, AVTR is less volatile compared to NXGLW. This indicates lower risk in terms of short-term price fluctuations for AVTR.Check NXGLW's competition here
Lucyd, Inc (NASDAQ: LUCYW)
AVTR vs LUCYW Comparison October 2026
Avantor, Inc. (NYSE: AVTR) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AVTR stands at 11.6B. In comparison, LUCYW has a market cap of 296.1K. Regarding current trading prices, AVTR is priced at $17.00 on the NYSE, while LUCYW trades at $0.06.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AVTR currently has a P/E ratio of 20.14, whereas LUCYW's P/E ratio is N/A. In terms of profitability, AVTR's ROE is -0.10%, compared to LUCYW's ROE of -0.89%. Regarding short-term risk, AVTR is less volatile compared to LUCYW. This indicates lower risk in terms of short-term price fluctuations for AVTR.Check LUCYW's competition here
NEXGEL, Inc. (NASDAQ: NXGL)
AVTR vs NXGL Comparison October 2026
Avantor, Inc. (NYSE: AVTR) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AVTR stands at 11.6B. In comparison, NXGL has a market cap of 90.2K. Regarding current trading prices, AVTR is priced at $17.00 on the NYSE, while NXGL trades at $4.13.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AVTR currently has a P/E ratio of 20.14, whereas NXGL's P/E ratio is -6.08. In terms of profitability, AVTR's ROE is -0.10%, compared to NXGL's ROE of -1.33%. Regarding short-term risk, AVTR is less volatile compared to NXGL. This indicates lower risk in terms of short-term price fluctuations for AVTR.Check NXGL's competition here
Invuity, Inc. (NASDAQ: IVTY)
AVTR vs IVTY Comparison October 2026
Avantor, Inc. (NYSE: AVTR) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AVTR stands at 11.6B. In comparison, IVTY has a market cap of 0. Regarding current trading prices, AVTR is priced at $17.00 on the NYSE, while IVTY trades at $7.39.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AVTR currently has a P/E ratio of 20.14, whereas IVTY's P/E ratio is -3.80. In terms of profitability, AVTR's ROE is -0.10%, compared to IVTY's ROE of -2.40%. Regarding short-term risk, AVTR is more volatile compared to IVTY. This indicates higher risk in terms of short-term price fluctuations for AVTR.Check IVTY's competition here
IntriCon Corporation (NASDAQ: IIN)
AVTR vs IIN Comparison October 2026
Avantor, Inc. (NYSE: AVTR) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AVTR stands at 11.6B. In comparison, IIN has a market cap of 0. Regarding current trading prices, AVTR is priced at $17.00 on the NYSE, while IIN trades at $24.23.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AVTR currently has a P/E ratio of 20.14, whereas IIN's P/E ratio is 226.45. In terms of profitability, AVTR's ROE is -0.10%, compared to IIN's ROE of -0.00%. Regarding short-term risk, AVTR is more volatile compared to IIN. This indicates higher risk in terms of short-term price fluctuations for AVTR.Check IIN's competition here
Analogic Corporation (NASDAQ: ALOG)
AVTR vs ALOG Comparison October 2026
Avantor, Inc. (NYSE: AVTR) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AVTR stands at 11.6B. In comparison, ALOG has a market cap of 0. Regarding current trading prices, AVTR is priced at $17.00 on the NYSE, while ALOG trades at $83.95.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AVTR currently has a P/E ratio of 20.14, whereas ALOG's P/E ratio is 40.93. In terms of profitability, AVTR's ROE is -0.10%, compared to ALOG's ROE of -0.15%. Regarding short-term risk, AVTR is more volatile compared to ALOG. This indicates higher risk in terms of short-term price fluctuations for AVTR.Check ALOG's competition here
Antares Pharma, Inc. (NASDAQ: ATRS)
AVTR vs ATRS Comparison October 2026
Avantor, Inc. (NYSE: AVTR) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AVTR stands at 11.6B. In comparison, ATRS has a market cap of 0. Regarding current trading prices, AVTR is priced at $17.00 on the NYSE, while ATRS trades at $5.59.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AVTR currently has a P/E ratio of 20.14, whereas ATRS's P/E ratio is 14.95. In terms of profitability, AVTR's ROE is -0.10%, compared to ATRS's ROE of +0.31%. Regarding short-term risk, AVTR is more volatile compared to ATRS. This indicates higher risk in terms of short-term price fluctuations for AVTR.Check ATRS's competition here
Hill-Rom Holdings, Inc. (NYSE: HRC)
AVTR vs HRC Comparison October 2026
Avantor, Inc. (NYSE: AVTR) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AVTR stands at 11.6B. In comparison, HRC has a market cap of 0. Regarding current trading prices, AVTR is priced at $17.00 on the NYSE, while HRC trades at $155.96.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AVTR currently has a P/E ratio of 20.14, whereas HRC's P/E ratio is 41.92. In terms of profitability, AVTR's ROE is -0.10%, compared to HRC's ROE of +0.14%. Regarding short-term risk, AVTR is more volatile compared to HRC. This indicates higher risk in terms of short-term price fluctuations for AVTR.Check HRC's competition here
Apria, Inc. (NASDAQ: APR)
AVTR vs APR Comparison October 2026
Avantor, Inc. (NYSE: AVTR) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AVTR stands at 11.6B. In comparison, APR has a market cap of 0. Regarding current trading prices, AVTR is priced at $17.00 on the NYSE, while APR trades at $37.50.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AVTR currently has a P/E ratio of 20.14, whereas APR's P/E ratio is 22.59. In terms of profitability, AVTR's ROE is -0.10%, compared to APR's ROE of +9.81%. Regarding short-term risk, AVTR is more volatile compared to APR. This indicates higher risk in terms of short-term price fluctuations for AVTR.Check APR's competition here